📊 UEEC Key Takeaways
Is United Health Products, Inc. (UEEC) a Good Investment?
United Health Products is in critical financial distress with zero revenue, negative stockholders' equity of -$3.9M, and a severe liquidity crisis (0.03x current ratio). The company is technically insolvent and burning cash at -$1.2M annually with no viable operational base, making bankruptcy an imminent risk without substantial capital restructuring.
Why Buy United Health Products, Inc. Stock? UEEC Key Strengths
- Company maintains SEC filing status indicating administrative continuity
UEEC Stock Risks: United Health Products, Inc. Investment Risks
- Zero revenue indicates non-operational business with complete loss of customer base
- Negative stockholders' equity means liabilities exceed assets - technical insolvency
- Critical liquidity crisis: current ratio of 0.03x leaves company unable to service obligations
- Operating cash flow of -$1.2M annually is unsustainable with only $65.2K cash remaining
- Interest coverage of -19.9x shows company cannot service debt
- High bankruptcy or liquidation risk without immediate capital infusion
Key Metrics to Watch
- Revenue generation and operational restart
- Cash burn rate and cash position depletion timeline
- Debt restructuring, capital raise, or bankruptcy announcements
United Health Products, Inc. (UEEC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
UEEC Profit Margin, ROE & Profitability Analysis
UEEC vs Healthcare Sector: How United Health Products, Inc. Compares
How United Health Products, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is United Health Products, Inc. Stock Overvalued? UEEC Valuation Analysis 2026
Based on fundamental analysis, United Health Products, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
United Health Products, Inc. Balance Sheet: UEEC Debt, Cash & Liquidity
UEEC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: United Health Products, Inc.'s revenue has declined by 100% over the 5-year period, indicating business contraction. The most recent EPS of $-0.01 indicates the company is currently unprofitable.
UEEC Revenue Growth, EPS Growth & YoY Performance
UEEC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | N/A | -$285.6K | $0.00 |
| Q2 2025 | N/A | -$315.2K | $0.00 |
| Q1 2025 | N/A | -$451.9K | $0.00 |
| Q3 2024 | N/A | -$303.7K | N/A |
| Q2 2024 | N/A | -$432.0K | N/A |
| Q1 2024 | N/A | -$451.9K | N/A |
| Q3 2023 | N/A | -$485.7K | $0.00 |
| Q2 2023 | N/A | -$522.9K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
United Health Products, Inc. Dividends, Buybacks & Capital Allocation
UEEC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for United Health Products, Inc. (CIK: 0001096938)
📋 Recent SEC Filings
❓ Frequently Asked Questions about UEEC
What is the AI rating for UEEC?
United Health Products, Inc. (UEEC) has an AI rating of STRONG SELL with 98% confidence, based on fundamental analysis of SEC EDGAR filings.
What are UEEC's key strengths?
Claude: Company maintains SEC filing status indicating administrative continuity.
What are the risks of investing in UEEC?
Claude: Zero revenue indicates non-operational business with complete loss of customer base. Negative stockholders' equity means liabilities exceed assets - technical insolvency.
What is UEEC's revenue and growth?
United Health Products, Inc. reported revenue of $0.0.
Does UEEC pay dividends?
United Health Products, Inc. does not currently pay dividends.
Where can I find UEEC SEC filings?
Official SEC filings for United Health Products, Inc. (CIK: 0001096938) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is UEEC's EPS?
United Health Products, Inc. has a diluted EPS of $-0.01.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is UEEC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, United Health Products, Inc. has a STRONG SELL rating with 98% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is UEEC stock overvalued or undervalued?
Valuation metrics for UEEC: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy UEEC stock in 2026?
Our dual AI analysis gives United Health Products, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is UEEC's free cash flow?
United Health Products, Inc.'s operating cash flow is $-1.2M, with capital expenditures of $0.0.
How does UEEC compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.03 (avg: 2).